Member Info for Laura2022

Good point KingH

PYC could be profitable if £1mln is hit

Tonl say in March they are confident of achieving £1mln they must be confident of visibility March to early June

Biostatistics service line

 

The Company was excited to announce its intention to develop a separate consulting service line focused on the delivery of biostatistics projects. Several complementary options are being pursued simultaneously to build out this new capability and a further update will be provided to the market towards the end of the current financial year.  We anticipate that, if successful, this new service line could make a material contribution to the Company's revenues and bottom line in the financial year ending 30 June 2025

Ahceiving £1mln for 2024 would make a mockery of current market value

PYC should be q much higher market value

As debull says

Losses coming down

Client mix improving

Pipeline growing

Cash equivalents healthy

Meeting market expectations and significantly higher than 2023

Not many companies can say the same

The Company's pipeline of potential new business now stands at over £1.5m (not risk weighted and excluding Biostatistics), counting only opportunities where a specific project has been discussed with a client. The Company is working hard to both convert opportunities that have progressed to proposal stage and also to refill the funnel with earlier stage opportunities.  A significant number of new client contracts are now originating from both scientific conferences (such as EORTC-NCI-AACR & AACR Annual Meeting) as well as more business focused meetings (such as BioEurope) and as such the Company intends to significantly increase its presence at such meetings over the course of this calendar year

The Directors are pleased that the Company is on track to meet expectations, which, if achieved, would mean a significant increase in total income compared with the financial year ended 30 June 2023

They have shareholder funds at half year of £672k v market cap of £1.8mlm and importantly costs will come down eg new flexible office e

They have RE ITERATES full year guidance (£1mln) so are clearly expecting a good next 3mths

Right across AIM shares,of all market capitalisation volume has been the lowest for years according to some .

Certainly I have noticed a marked change in the last 12mths ,

As for JM he has always had several other roles and is "fully committed " according to the Q and A

Usually PYC state if they at attending I think ?

Great to see

I sold this morning for 100% but so nice to see you all doing well at 200%

From £500k value this was sure to do well with some good news..which arrive s

PYC at £1.8mlm cap is crazy cheap too

I have sold my purchases at 0.3p taken in January

Good luck

Hence Physiomics will receive £137,376 over the course of the Project which will start immediately

They are reporting on the half year which are a) known b) under Jim

When Peter did the presentations recently they've had every opportunity to state whether they are no longer targeting the "best ever income of £1mln" for full year June 2023/24 so one would hope Peter wouldn't be foolish enough to over promise

Looking at the income and contracts H1 it looks like about £350-400k H1 (£125k + £130k grant income + 3 or 4 other contracts)

Thursday 7th March for half year ended Dec 2023

Since the 2nd Feb presentation there have been updates on 5th 6th and 19th Feb, would like to see bigger contracts now (albeit the range can be varied £50k to £250k+) and hopefully cumulative

Has anyone contacted Peter yet? I am happy to try if that email debull put here is the correct one ?

From the presentation

Options for Peter will be released via RNS

Jim entirely committed to PYC and to work with the team

Peter driving revenues and last few months seen "pipleine momentum"

27 29 significant progress in pipeline "very busy" over last month signals "very positive from new and existing clients" and "watch this space " in terms of updates on contracts

29 project optimus

Shroeders stil had about 10mln+ às of yesterday

Have they been sold yet ?

According to VAL they will put new requisitions in soon

I just wish the whole VAL201 situation would be resolved one way or the other, their last update was 2mths ago saying they are still confident of the merger

Surely at someone there has to be some proof from VAL/merger documents that it either is or isn't happening

A 2nd rns from Schroeders who went 10^ to 9%

Unless there was also large sells today ?

On VAL they've asked Suzy for a final conclusive update on where they are with the EUDA merger

Not sure whether it will work in terms of forcing an update e?

I'm personally not being either...just stating an opinion

SED have said there are offers BUT who hold the cards

I'll certainly be watching

Gluck all holders

The easiest and safest way to sell is while SED it listed

If it leaves the market you have to you use a cumbersome matched bargain facility where you need a private buyer for your dhares

They are minimal cost, as KingH says,you pay annual a few ££hundred